Financial News
Passage Bio, Inc. - Common Stock (NQ:PASG)
Price and Volume
Detailed Quote| Volume | 210 |
| Open | 4.820 |
| Bid (Size) | 4.500 (1,500) |
| Ask (Size) | 7.710 (200) |
| Prev. Close | 4.820 |
| Today's Range | 4.820 - 4.820 |
| 52wk Range | 3.290 - 20.00 |
| Shares Outstanding | 61,767,286 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read More
Passage Bio to Participate in Upcoming Investor Conferences
February 19, 2026
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
August 12, 2025
Friday's session: top gainers and losers ↗
July 25, 2025
Gapping stocks in Friday's session ↗
July 25, 2025
What's going on in today's after hours session ↗
July 11, 2025
Passage Bio Announces 1-for-20 Reverse Stock Split
July 10, 2025
Frequently Asked Questions
Is Passage Bio, Inc. - Common Stock publicly traded?
Yes, Passage Bio, Inc. - Common Stock is publicly traded.
What exchange does Passage Bio, Inc. - Common Stock trade on?
Passage Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Passage Bio, Inc. - Common Stock?
The ticker symbol for Passage Bio, Inc. - Common Stock is PASG on the Nasdaq Stock Market
What is the current price of Passage Bio, Inc. - Common Stock?
The current price of Passage Bio, Inc. - Common Stock is 4.820
When was Passage Bio, Inc. - Common Stock last traded?
The last trade of Passage Bio, Inc. - Common Stock was at 07/08/26 04:00 PM ET
What is the market capitalization of Passage Bio, Inc. - Common Stock?
The market capitalization of Passage Bio, Inc. - Common Stock is 297.72M
How many shares of Passage Bio, Inc. - Common Stock are outstanding?
Passage Bio, Inc. - Common Stock has 298M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
